MPS Pharmaa Ltd Share Price

₹1.85 0.00 (0.00%) BSE
as updated on 22-Dec-2025 16:59 | Sector - Healthcare

Day Range

  • Day's Low:0.00
  • Day's High:0.00

  • 52 Week Low1.76
  • 52 Week High4.33

MPS Pharmaa Ltd's key Fundamentals

Market Cap ₹4 Cr.
P/E Ratio 0
TTM EPS -0.5
P/B Ratio 5.52
ROE -58.89
Debt to Equity 6.90
Face Value 10
BVPS 0.3
3 Year Sales Growth -100.00%

MPS Pharmaa Ltd's Share Price Returns

1 Day 0.00%
1 Week 4.50%
1 Month 5.10%
3 Months -7.00%
6 Months -35.50%
1 Years -56.90%
3 Years 0.00%
5 Years 0.00%
10 Years 0%

Financial Ratio Analysis

Adj EPS (Rs.)
Sales (Cr.)
ROE (%)
ROCE (%)

Check our DeciZen before investing

Check Stock Quality
Check Stock Valuation
Check Price Trend

MPS Pharmaa Ltd Shareholding Pattern

Promoters

(35.89%)

Institutions

(0.00%)

Non-Institutions

(64.11%)

Pledged shares as % of Promoter's holding (%)

(16.04%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Balance Sheet

(All Figures are in Crores.)

Profit And Loss

(All Figures in Cr. Adjusted EPS in Rs.)

Cash Flow

(All Figures are in Crores.)

About MPS Pharmaa Ltd

Advik Laboratories has been set up by V K Jain, a qualified production chemist with over 20 years experience in pharmaceutical products.

Advik Laboratories was established in the 1994. It is WHO-GMP certified company that has been set up from the ground level with the avowed objective of achieving USFDA standards of quality.

The company has a technical collaboration with PFC Pharma Focus of Switzerland. It enjoys leadership status at various fronts such as high product quality, a growing range of products, state of the art manufacturing process, competitive pricing and customer service. In addition the company exports a wide range of drugs to the Middle East, South America and Africa.

The product range includes ethical, generic drugs and over the counter drugs (OTC) in various formulations.

With over 60,000 square feet of built-up area, ample developed open space around it, a state-of-the-art manufacturing facility, the ground floor has provisions for the production and in-process control section for the manufacturing of steroidal & non-steroidal formulations, change room for gents & ladies and stores for raw & packing materials. The first floor has provision for the production and in-process control section for the manufacturing of ampicillin and non-ampicillin capsules and dry syrup preparations. The second floor has provision for quality control and about 12000 sq ft area is presently being reserved for the manufacture of injectables & ointments in the second phase.

Advik Laboratories provides pharmaceutical formulations that match the international standards of quality. The facility manufactures a wide range of pharmaceuticals formulations in tablets, capsules and dry syrups.

Products - Under Ethical products, the company manufactures Wibatol, Wibatol-O, Robial, Twosum, Majispa, Arfa Gel, Stibomin and Chewfe-C.

Under generic products, the company manufactures drugs catering segment such as antibacterials, antiallergics, antifungals, analgesic, antipyretic and anti-inflammatory, anti-hypertensives, anthelminthics, anti-malarials, corticosteroids, erectile dysfunction, gastrointestinal agents and sedatives.

Award - Advik Laboratories has received the prestigious Udyog Patra Award from the Government of India in 1999.

Read More Read Less
Read More Read Less

Investment related blogs

Day Range

  • Day's Low: 0.00
  • Day's High: 0.00

  • 52 Week Low1.76
  • 52 Week High4.33

MPS Pharmaa Ltd's key Fundamentals

Market Cap ₹4 Cr.
P/E Ratio 0
TTM EPS -0.5
P/B Ratio 5.52
ROE -58.89
Debt to Equity 6.90
Face Value 10
BVPS 0.3
3 Year Sales Growth -100.00%

MPS Pharmaa Ltd's Share Price Returns

1 Day 0.00%
1 Week 4.50%
1 Month 5.10%
3 Months -7.00%
6 Months -35.50%
1 Years -56.90%
3 Years 0.00%
5 Years 0.00%
10 Years 0%

Investment related blogs

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×